Washington, DC (May 6, 2009) – In this period of economic uncertainty, many uninsured and underinsured Americans are going online to seek help getting the prescription medicines they need. America’s pharmaceutical research and biotechnology companies want patients to know that they can rely on the Partnership for Prescription Assistance (PPA) to help them confidentially – and for free.
The PPA, a nationwide effort sponsored by America’s pharmaceutical research companies, provides a single point of access to more than 475 patient assistance programs that help those who are uninsured or struggling financially. Nearly 200 of the programs are provided by pharmaceutical companies.
“For four years, the PPA has been a trusted resource for nearly six million Americans. The program is completely free to use and, importantly, is comprehensive, allowing struggling patients to search from hundreds of assistance programs, both public and private,” said Billy Tauzin, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Although other programs provide patients with information similar to what is available through the PPA, many of those programs may charge fees, either on a one-time or an ongoing basis. However, the PPA is one of the available programs that charge nothing for the service.
“The PPA is not for profit. It’s a free service, a free phone call, and in many cases, the medicines are free, too,” Tauzin added.
Unfortunately, according to published reports, some other programs operate solely to make money, without providing patients with the help that they need. The PPA, which has helped more than 5.7 million Americans in four years, has proven to those millions of Americans, and their loved ones, that the help available is real.
“If you’re looking for assistance and are unsure about whether the program you’re contacting is trustworthy, take a few moments to call the PPA instead,” urged Ken Johnson, PhRMA Senior Vice President.
Patients who qualify for help from the PPA’s participating patient assistance programs have access to more than 2,500 brand-name and generic prescription medicines. In addition, the PPA provides information on more than 10,000 free health care clinics in America and has connected more than 277,000 patients with clinics and health care providers in their communities.
Access to this information is more important now than ever before.
“At a time when national unemployment is the highest in almost two decades, the PPA has become an important lifeline for a growing number of patients,” PhRMA’s Tauzin said. “Millions of Americans have been added to the jobless rolls over the last several months and there could be a sharp increase in the number of our citizens losing health care benefits.’’
“PPA is currently helping thousands of people every day,” Tauzin added, including those who need treatments to fight such debilitating chronic diseases as cancer, heart disease, diabetes and asthma.
To find out if there are patient assistance programs that may meet their needs, patients should call toll-free 1-888-4PPA-NOW (1-888-477-2669) to speak with a trained specialist or visit www.pparx.org.
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.
PhRMA Internet Address: http://www.phrma.org
For information on how innovative medicines save lives, visit: http://www.innovation.org
For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org
For more information on public health emergencies, visit http://www.rxresponse.org
For information on the danger of imported drugs, visit: http://www.buysafedrugs.info